Skip to content

Pawel Botwina

Pawel Botwina M.Sc.
PhD Student
Faculty of Biochemistry, Biophysics and Biotechnology
E-mail: pawel.botwina [AT] doctoral.uj.edu.pl

Research interests

  • Development of novel inhibitory compounds against viral diseases.

Education & Experience
Show More

    1. 2016 - : Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University. PhD studies.
    2. 2014-2016 : Jagiellonian University, Faculty of Biochemistry, Biophysics and Biotechnology, Krakow, Poland (M.Sc. studies)
    3. 2011 - 2014: Jagiellonian University, Faculty of Biology and Earth Sciences, Krakow, Poland (B.Sc. studies)
    4. 2008 - 2011: Maria Curie Sklodowska High School, Jaroslaw, Poland

    1. Milewska A, Chi Y, Szczepanski A, Barreto-Duran E, Dabrowska A, Botwina P, Liu K, Liu D, Guo X, Ge Y, Li J, Cui L, Ochman M, Urlik M, Rodziewicz-Motowidlo S, Zhu F, Szczubialka K, Nowakowska M, Pyrc K. (2020). HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV. Journal of Virology. in press.
    2. Botwina P, Obłoza M, Szczepański A, Szczubiałka K, Nowakowska M, Pyrc K. In Vitro Inhibition of Zika Virus Replication with Poly(Sodium 4-Styrenesulfonate). (2020). Viruses. 2020 Aug 23;12(9):E926.
    3. Botwina P, Owczarek K, Rajfur Z, Ochman M, Urlik M, Nowakowska M, Szczubiałka K, Pyrc K. Berberine hampers influenza A replication through inhibition of MAPK/ERK pathway. (2020). Viruses. in press.
    4. Ciejka J, Botwina P, Nowakowska M, Szczubiałka K, Pyrc K. Synthetic sulfonated derivatives of poly(allylamine hydrochloride) as inhibitors of human metapneumovirus. PLoS One. 14(3):e0214646.